ISG15 and neoplasm: Increasing ISG15+ cells were detected in both the tumour region and normal bowel wall of patients with partial response for ICI treatment (Figure 7J), whereas ISG15+ CD68+ macrophages were only enriched in the normal bowel wall, indicating their proinflammatory phenotypes in the bowel wall (Figure 7K).